{"pmid":32227757,"title":"Developing Covid-19 Vaccines at Pandemic Speed.","text":["Developing Covid-19 Vaccines at Pandemic Speed.","N Engl J Med","Lurie, Nicole","Saville, Melanie","Hatchett, Richard","Halton, Jane","32227757"],"journal":"N Engl J Med","authors":["Lurie, Nicole","Saville, Melanie","Hatchett, Richard","Halton, Jane"],"date":"2020-04-01T11:00:00Z","year":2020,"_id":"32227757","week":"202014|Mar 30 - Apr 05","doi":"10.1056/NEJMp2005630","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1662819280246276096,"score":7.334329,"similar":[{"pmid":32148172,"title":"Timely development of vaccines against SARS-CoV-2.","text":["Timely development of vaccines against SARS-CoV-2.","Emerg Microbes Infect","Lu, Shan","32148172"],"journal":"Emerg Microbes Infect","authors":["Lu, Shan"],"date":"2020-03-10T11:00:00Z","year":2020,"_id":"32148172","week":"202011|Mar 09 - Mar 15","doi":"10.1080/22221751.2020.1737580","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1662334543892316161,"score":51.137882},{"pmid":32098302,"title":"Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development.","text":["Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development.","Novel Coronavirus (2019-nCoV) is an emerging pathogen that was first identified in Wuhan, China in late December 2019. This virus is responsible for the ongoing outbreak that causes severe respiratory illness and pneumonia-like infection in humans. Due to the increasing number of cases in China and outside China, the WHO declared coronavirus as a global health emergency. Nearly 35,000 cases were reported and at least 24 other countries or territories have reported coronavirus cases as early on as February. Inter-human transmission was reported in a few countries, including the United States. Neither an effective anti-viral nor a vaccine is currently available to treat this infection. As the virus is a newly emerging pathogen, many questions remain unanswered regarding the virus's reservoirs, pathogenesis, transmissibility, and much more is unknown. The collaborative efforts of researchers are needed to fill the knowledge gaps about this new virus, to develop the proper diagnostic tools, and effective treatment to combat this infection. Recent advancements in plant biotechnology proved that plants have the ability to produce vaccines or biopharmaceuticals rapidly in a short time. In this review, the outbreak of 2019-nCoV in China, the need for rapid vaccine development, and the potential of a plant system for biopharmaceutical development are discussed.","Pathogens","Shanmugaraj, Balamurugan","Malla, Ashwini","Phoolcharoen, Waranyoo","32098302"],"abstract":["Novel Coronavirus (2019-nCoV) is an emerging pathogen that was first identified in Wuhan, China in late December 2019. This virus is responsible for the ongoing outbreak that causes severe respiratory illness and pneumonia-like infection in humans. Due to the increasing number of cases in China and outside China, the WHO declared coronavirus as a global health emergency. Nearly 35,000 cases were reported and at least 24 other countries or territories have reported coronavirus cases as early on as February. Inter-human transmission was reported in a few countries, including the United States. Neither an effective anti-viral nor a vaccine is currently available to treat this infection. As the virus is a newly emerging pathogen, many questions remain unanswered regarding the virus's reservoirs, pathogenesis, transmissibility, and much more is unknown. The collaborative efforts of researchers are needed to fill the knowledge gaps about this new virus, to develop the proper diagnostic tools, and effective treatment to combat this infection. Recent advancements in plant biotechnology proved that plants have the ability to produce vaccines or biopharmaceuticals rapidly in a short time. In this review, the outbreak of 2019-nCoV in China, the need for rapid vaccine development, and the potential of a plant system for biopharmaceutical development are discussed."],"journal":"Pathogens","authors":["Shanmugaraj, Balamurugan","Malla, Ashwini","Phoolcharoen, Waranyoo"],"date":"2020-02-27T11:00:00Z","year":2020,"_id":"32098302","week":"20209|Feb 24 - Mar 01","doi":"10.3390/pathogens9020148","keywords":["biopharmaceuticals","coronavirus","emerging threat","infectious diseases","plant system","transient expression","viruses","zoonoses"],"source":"PubMed","locations":["China","United States","Wuhan"],"countries":["China","United States"],"countries_codes":["CHN|China","USA|United States"],"topics":["Treatment"],"weight":1,"_version_":1662334544287629312,"score":43.8761},{"pmid":32226821,"pmcid":"PMC7094090","title":"Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases.","text":["Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases.","ACS Cent Sci","Liu, Cynthia","Zhou, Qiongqiong","Li, Yingzhu","Garner, Linda V","Watkins, Steve P","Carter, Linda J","Smoot, Jeffrey","Gregg, Anne C","Daniels, Angela D","Jervey, Susan","Albaiu, Dana","32226821"],"journal":"ACS Cent Sci","authors":["Liu, Cynthia","Zhou, Qiongqiong","Li, Yingzhu","Garner, Linda V","Watkins, Steve P","Carter, Linda J","Smoot, Jeffrey","Gregg, Anne C","Daniels, Angela D","Jervey, Susan","Albaiu, Dana"],"date":"2020-04-01T11:00:00Z","year":2020,"_id":"32226821","week":"202014|Mar 30 - Apr 05","doi":"10.1021/acscentsci.0c00272","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1662819280315482113,"score":42.35437},{"pmid":32186952,"title":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics.","text":["COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics.","The novel coronavirus infection (COVID-19 or Coronavirus disease 2019) that emerged from Wuhan, Hubei province of China has spread to many countries worldwide. Efforts have been made to develop vaccines against human coronavirus (CoV) infections such as MERS and SARS in the past decades. However, to date, no licensed antiviral treatment or vaccine exists for MERS and SARS. Most of the efforts for developing CoV vaccines and drugs target the spike glycoprotein or S protein, the major inducer of neutralizing antibodies. Although a few candidates have shown efficacy in in vitro studies, not many have progressed to randomized animal or human trials, hence may have limited use to counter COVID-19 infection. This article highlights ongoing advances in designing vaccines and therapeutics to counter COVID-19 while also focusing on such experiences and advances as made with earlier SARS- and MERS-CoVs, which together could enable efforts to halt this emerging virus infection.","Hum Vaccin Immunother","Dhama, Kuldeep","Sharun, Khan","Tiwari, Ruchi","Dadar, Maryam","Malik, Yashpal Singh","Singh, Karam Pal","Chaicumpa, Wanpen","32186952"],"abstract":["The novel coronavirus infection (COVID-19 or Coronavirus disease 2019) that emerged from Wuhan, Hubei province of China has spread to many countries worldwide. Efforts have been made to develop vaccines against human coronavirus (CoV) infections such as MERS and SARS in the past decades. However, to date, no licensed antiviral treatment or vaccine exists for MERS and SARS. Most of the efforts for developing CoV vaccines and drugs target the spike glycoprotein or S protein, the major inducer of neutralizing antibodies. Although a few candidates have shown efficacy in in vitro studies, not many have progressed to randomized animal or human trials, hence may have limited use to counter COVID-19 infection. This article highlights ongoing advances in designing vaccines and therapeutics to counter COVID-19 while also focusing on such experiences and advances as made with earlier SARS- and MERS-CoVs, which together could enable efforts to halt this emerging virus infection."],"journal":"Hum Vaccin Immunother","authors":["Dhama, Kuldeep","Sharun, Khan","Tiwari, Ruchi","Dadar, Maryam","Malik, Yashpal Singh","Singh, Karam Pal","Chaicumpa, Wanpen"],"date":"2020-03-19T11:00:00Z","year":2020,"_id":"32186952","week":"202012|Mar 16 - Mar 22","doi":"10.1080/21645515.2020.1735227","keywords":["COVID-19","Emerging coronavirus","drugs","therapeutics","vaccines"],"source":"PubMed","locations":["China","Hubei","Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment"],"weight":1,"_version_":1662334543499100160,"score":40.96262}]}